Loading: 100%
FEMALE HEALTH CO logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 156 (as per FY 2016)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker VERUno data available
Financial year endsFY ends End of Septemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,000,751,502,253,00
datesClosing price (adj.)
13.10.20171.99
11.10.20171.99
04.10.20171.99
27.09.20172.84
20.09.20171.80
13.09.20171.50
06.09.20171.53
30.08.20171.62
23.08.20171.45
16.08.20171.35
09.08.20171.33
02.08.20171.20
26.07.20171.14
19.07.20171.06
12.07.20171.09
05.07.20171.06
27.06.20171.19
20.06.20171.21
13.06.20171.21
06.06.20171.16
30.05.20171.27
23.05.20171.05
16.05.20171.01
09.05.20171.01
02.05.20171.06
25.04.20170.92
18.04.20170.95
11.04.20170.94
04.04.20171.01
28.03.20171.04
21.03.20171.02
14.03.20171.06
07.03.20171.01
28.02.20171.01
21.02.20171.04
14.02.20171.09
07.02.20171.05
31.01.20171.03
24.01.20171.03
17.01.20171.01
10.01.20171.01
03.01.20170.92
27.12.20160.99
19.12.20160.99
12.12.20161.07
05.12.20161.09
28.11.20161.07
21.11.20161.16
14.11.20160.87
07.11.20160.92
31.10.20160.95
24.10.20161.08
17.10.20161.06
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
1.99n/a
Market Capitalisation
in million USD
58n/a
Enterprise Value
in million USD
55n/a
Common Shares Outstanding
as per Sep 30, 2016
29,090,250n/a
Preferred Shares Outstanding
as per Sep 30, 2016
n/a
Average Basic Shares Outstanding
TTM
30,418,436n/a
Average Diluted Shares Outstanding
TTM
30,387,164n/a
Index Membership
n/a
Business Summary
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 3n/a
Receivables 6n/a
Total Current Assets 12n/a
PP&E 1n/a
Total Assets 57n/a
Accounts Payable 2n/a
Current Debt 0n/a
Total Current Liabilities 5n/a
Long-Term Debt 0n/a
Total Liabilities 7n/a
Total Equity 51n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 1.08n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 1.19n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.88n/a
Other Ratios
Current Ratio 247.1%n/a
Liabilities to Equity Ratio 13.1%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
28
22
19
35
31
24
33
22
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-14
-9
-9
-14
-14
-11
-14
-9
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
14
13
10
21
18
13
19
13
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-7
-7
-7
-10
-7
-9
-12
-9
Selling, General & Administrative
-7
-7
-7
-10
-7
-9
-12
-9
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
6
6
3
11
10
4
7
5
Non-Operating Income (Loss)
0
0
0
0
0
0
0
0
Interest Expense, net
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
6
6
3
11
10
4
7
5
Abnormal Gains (Losses)
-2
-2
0
0
0
0
0
-2
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
4
4
3
11
10
4
7
3
Income Tax (Expense) Benefit, net
1
3
2
5
4
-2
-2
-2
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
6
7
6
16
14
2
4
1
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
6
7
6
16
14
2
4
1
Minority Interest
0
0
0
0
0
0
0
0
Net Income
6
7
6
16
14
2
4
1
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
6
7
6
16
14
2
4
1
Remarks
restated on Dec 2, 2011 n/a
calculated values,
restated on Dec 4, 2012 n/a
calculated values,
restated on Dec 3, 2013 n/a
calculated values,
restated on Dec 2, 2014 n/a
calculated values,
restated on Dec 2, 2015 n/a
calculated values,
restated on Dec 12, 2016 n/a
calculated values,
restated on Dec 12, 2016 n/a
calculated values,
restated on Dec 12, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
3
4
5
9
6
4
2
Cash & Cash Equivalents
n/a
3
4
5
9
6
4
2
Short Term Investments
n/a
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
4
2
7
2
3
14
11
Accounts Receivable, Net
n/a
4
2
7
2
3
14
11
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
2
2
1
2
3
2
2
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
2
1
3
3
1
2
1
Prepaid Expenses
n/a
0
0
1
1
1
1
1
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
2
1
2
3
1
1
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
Total Current Assets
n/a
12
10
17
17
13
22
16
Property, Plant & Equipment, Net
n/a
2
2
2
2
2
1
1
Property, Plant & Equipment
n/a
4
4
5
5
5
5
5
Accumulated Depreciation
n/a
-1
-2
-2
-3
-3
-4
-4
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
4
8
11
16
17
15
22
Intangible Assets
n/a
0
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
4
8
11
16
17
15
13
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
0
0
8
Total Noncurrent Assets
n/a
7
10
14
18
19
16
22
Total Assets
n/a
18
19
30
35
32
37
39
Liabilities and owners' equity
Payables & Accruals
n/a
1 1031439
1 1446819
5 4740139
2 1866742
2 1561702
2 1669777
1 965906
Accounts Payable
n/a
1 586596
1 1076994
2 1775327
1 904049
1 1124859
1 1077349
1 701035
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 444843
0 369825
3 2964812
1 962693
0 436843
1 592428
0 264871
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
1 906994
1 846591
1 1120302
2 1598276
2 1816508
3 2555231
2 2380571
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
1 906994
1 846591
1 1120302
2 1598276
2 1816508
3 2555231
2 2380571
Total Current Liabilities
n/a
2 1938433
2 2293410
6 5860441
3 3465018
3 3378210
4 4225008
3 3346477
Long Term Debt
n/a
0 12999
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
0 284539
0 396791
0 367796
0 301978
0 229618
0 113641
1 1343819
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 132312
0 107481
0 82650
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 152227
0 188177
0 194244
0 235179
0 190513
0 98252
0 110069
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 0
0 101133
0 90902
0 66799
0 39105
0 15389
1 1233750
Total Noncurrent Liabilities
n/a
0 297538
0 396791
0 367796
0 301978
0 229618
0 113641
1 1343819
Total Liabilities
n/a
2 2235971
3 2690201
6 6228237
4 3766996
4 3607828
4 4338649
5 4690296
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
68 67607291
68 68413872
67 67066407
68 67767426
69 68794476
70 69517126
70 69972750
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-6 -6349569
-6 -6382632
-7 -6672243
-7 -7067910
-8 -7805655
-8 -7806605
-8 -7806605
Retained Earnings
n/a
-45 -44544073
-45 -44697131
-36 -35594455
-29 -28715040
-32 -32341976
-28 -27995940
-28 -27651215
Other Equity
n/a
-1 -581519
-1 -581519
-1 -581519
-1 -581519
-1 -581519
-1 -581519
-1 -581519
Equity Before Minority Interest
n/a
16 16132130
17 16752590
24 24218190
31 31402957
28 28065326
33 33133062
34 33933411
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
16 16132130
17 16752590
24 24218190
31 31402957
28 28065326
33 33133062
34 33933411
Total Liabilities & Equity
n/a
18 18368101
19 19442791
30 30446427
35 35169953
32 31673154
37 37471711
39 38623707
Remarks restated on n/a restated on Dec 2, 2011 n/a restated on Dec 4, 2012 n/a restated on Dec 3, 2013 n/a restated on Dec 2, 2014 n/a restated on Dec 2, 2015 n/a restated on Dec 12, 2016 n/a restated on Aug 9, 2017 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
7
7
5
15
14
2
4
0
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
1
1
0
0
Non-Cash Items
-1
-3
-2
-4
-5
2
3
3
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
0
0
3
-2
1
-1
-9
-5
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
6
4
7
10
12
4
-2
-2
Change in Fixed Assets & Intangibles
-2
0
0
-1
0
0
0
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-2
0
0
-1
0
0
0
0
Dividends Paid
0
-4
-6
-6
-7
-6
0
0
Cash From (Repayment of) Debt
0
1
0
0
0
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-3
0
0
0
0
-1
0
0
Increase in Capital Stock
0
0
0
0
0
0
0
0
Decrease in Capital Stock
-4
0
0
0
0
-1
0
0
Other Financing Activities
0
0
0
-2
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
-3
-4
-6
-9
-8
-7
0
0
Net Cash Before Disc. Operations and FX
1
0
1
1
4
-3
-2
-2
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
1
0
1
1
4
-3
-2
-2
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
Net Changes in Cash
1
0
1
1
4
-3
-2
-2
Remarks
restated on Dec 2, 2011 n/a
calculated values,
restated on Dec 4, 2012 n/a
calculated values,
restated on Dec 3, 2013 n/a
calculated values,
restated on Dec 2, 2014 n/a
calculated values,
restated on Dec 2, 2015 n/a
calculated values,
restated on Dec 12, 2016 n/a
calculated values,
restated on Dec 12, 2016 n/a
calculated values,
restated on Dec 12, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo